Throat Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: T4799DFAF0C4EN
Market Monitor Global

Abstracts

Laryngeal cancer are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx.Oropharyngeal cancer is a disease in which cancer form in the tissues of the throat (oropharynx).

This report contains market size and forecasts of Throat Cancer Therapeutics in Global, including the following market information:

Global Throat Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Throat Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Throat Cancer Therapeutics include Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co., Inc. and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Throat Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Throat Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Throat Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Surgery
• Radiotherapy
• Chemotherapy

Global Throat Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Throat Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Oropharyngeal Cancer
• Laryngeal Cancer

Global Throat Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Throat Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Throat Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Throat Cancer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Throat Cancer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Throat Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL THROAT CANCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Throat Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Throat Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Throat Cancer Therapeutics Players in Global Market
3.2 Top Global Throat Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Throat Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Throat Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Throat Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Throat Cancer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Throat Cancer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Throat Cancer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Throat Cancer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Surgery
  4.1.3 Radiotherapy
  4.1.4 Chemotherapy
4.2 By Type - Global Throat Cancer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Throat Cancer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Throat Cancer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Throat Cancer Therapeutics Market Size, 2021 & 2028
  5.1.2 Oropharyngeal Cancer
  5.1.3 Laryngeal Cancer
5.2 By Application - Global Throat Cancer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Throat Cancer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Throat Cancer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Throat Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Throat Cancer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Throat Cancer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Throat Cancer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Throat Cancer Therapeutics Revenue, 2017-2028
  6.3.2 US Throat Cancer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Throat Cancer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Throat Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Throat Cancer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.3 France Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Throat Cancer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Throat Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Throat Cancer Therapeutics Revenue, 2017-2028
  6.5.2 China Throat Cancer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Throat Cancer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Throat Cancer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Throat Cancer Therapeutics Market Size, 2017-2028
  6.5.6 India Throat Cancer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Throat Cancer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Throat Cancer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Throat Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Throat Cancer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Throat Cancer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Throat Cancer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Throat Cancer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bristol-Myers Squibb Co.
  7.1.1 Bristol-Myers Squibb Co. Corporate Summary
  7.1.2 Bristol-Myers Squibb Co. Business Overview
  7.1.3 Bristol-Myers Squibb Co. Throat Cancer Therapeutics Major Product Offerings
  7.1.4 Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bristol-Myers Squibb Co. Key News
7.2 Eli Lilly and Co.
  7.2.1 Eli Lilly and Co. Corporate Summary
  7.2.2 Eli Lilly and Co. Business Overview
  7.2.3 Eli Lilly and Co. Throat Cancer Therapeutics Major Product Offerings
  7.2.4 Eli Lilly and Co. Throat Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly and Co. Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Corporate Summary
  7.4.2 Merck & Co., Inc. Business Overview
  7.4.3 Merck & Co., Inc. Throat Cancer Therapeutics Major Product Offerings
  7.4.4 Merck & Co., Inc. Throat Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co., Inc. Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Throat Cancer Therapeutics Major Product Offerings
  7.5.4 Sanofi Throat Cancer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Throat Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Throat Cancer Therapeutics Market Drivers in Global Market
Table 3. Throat Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Throat Cancer Therapeutics in Global Market
Table 5. Top Throat Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Throat Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Throat Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Throat Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Throat Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Throat Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Throat Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Throat Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Throat Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Throat Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Throat Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Throat Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Throat Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Co. Corporate Summary
Table 31. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Co. Corporate Summary
Table 34. Eli Lilly and Co. Throat Cancer Therapeutics Product Offerings
Table 35. Eli Lilly and Co. Throat Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Product Offerings
Table 38. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc. Corporate Summary
Table 40. Merck & Co., Inc. Throat Cancer Therapeutics Product Offerings
Table 41. Merck & Co., Inc. Throat Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Throat Cancer Therapeutics Product Offerings
Table 44. Sanofi Throat Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Throat Cancer Therapeutics Segment by Type in 2021
Figure 2. Throat Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Throat Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Throat Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Throat Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Throat Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Throat Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Throat Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Co. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Co. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc. Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Throat Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)